Encompass Health revenue and financials

EHC · NYSE · USD

$122.63Change from previous close: −1.65%Absolute change: −$2.06

Close · October 7, 2026

In the fiscal year ended December 2025, Encompass Health reported revenue of $5.94B (+10.46% year over year). Net income was $566.2M, a net margin of 9.5%.

Annual revenue · 2025: $5.94B
  1. $4.01B2021
  2. $4.35B2022
  3. $4.8B2023
  4. $5.37B2024
  5. $5.94B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+10.46%
2025 vs 2024
Net income growth
+24.25%
2025 vs 2024
Net margin
9.5%
2024: 8.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Annual
Item20252024202320222021
Operating cash flow1,1761,003851706716
Depreciation and amortization328300274244220
Capital expenditure-736-643-583-584-546
Investing cash flow-765-653-603-627-666
Financing cash flow-431-331-197-146-240
Dividends paid-71.1-62.8-60.4-99.0-112
Share repurchases-178-43.2-8.2-7.3-14.6
Debt issued21095.080.0252—
Debt repaid-239-337-163-750—
Net change in cash-20.218.950.8-66.9-191
Free cash flow439360268122170
Levered free cash flow297216124-3.3-73.9